Welcome to our dedicated page for National Vision SEC filings (Ticker: EYE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From low-cost eye exams at America’s Best to Vision Centers hosted inside Walmart, National Vision’s growth story lives inside its SEC disclosures. We bring every National Vision SEC filing explained simply, turning hundreds of optical-retail pages into clear takeaways you can act on.
Need the numbers fast? Our AI-powered summaries break down —
- National Vision quarterly earnings report 10-Q filing: store-level comps, lens lab capacity and managed-care mix.
- National Vision annual report 10-K simplified: segment margins, lease obligations and clinic expansion risks.
- National Vision 8-K material events explained: partner renewals, leadership changes and unexpected disruptions.
- National Vision insider trading Form 4 transactions with real-time alerts, plus a complete log of National Vision executive stock transactions Form 4.
- National Vision proxy statement executive compensation insights, including optometrist incentive structures.
Every document hits our site the moment it posts to EDGAR, so National Vision Form 4 insider transactions real-time alerts arrive before the market digests them. Interactive charts and plain-English notes support understanding National Vision SEC documents with AI, letting you compare eyewear unit economics across quarters or perform National Vision earnings report filing analysis without sifting through footnotes.
Whether you’re monitoring optical retail trends, verifying compliance metrics, or watching National Vision insider trading Form 4 transactions, our platform gives you the clarity and speed needed to make informed decisions.
National Vision Holdings, Inc. (EYE) – Form 4 filing dated 06/23/2025
Director Susan C. O’Farrell reported the award of 9,674 restricted stock units (RSUs) on 06/18/2025. Each RSU converts into one share of common stock and will vest 100 % on the first anniversary of the grant date. The grant was recorded at $0 acquisition cost, indicating it is an equity-based compensation award rather than an open-market purchase.
Following the grant, O’Farrell’s total beneficial ownership increased to 22,333 shares, all held directly. No derivative securities or sales were disclosed. The transaction modestly increases insider alignment with shareholders, while the share count involved is immaterial relative to EYE’s outstanding shares and therefore has no meaningful dilutive impact.
National Vision Holdings, Inc. (EYE) – Form 4 filing overview:
Director James M. McGrann reported the grant of 7,392 restricted stock units (RSUs) on 18 June 2025. Each RSU represents the right to receive one share of common stock and will vest in full on the first anniversary of the grant date. Following the award, McGrann’s direct beneficial ownership rises to 10,719 shares. The transaction was coded “A” (acquired) and carries a price of $0, indicating it is part of routine director compensation rather than an open-market purchase.
No derivative securities were reported, and there are no indications of sales or dispositions. The disclosure is single-person, routine, and compensation-related, with limited immediate market impact.
National Vision Holdings (EYE) – Form 4 filing overview: On 06/18/2025, independent director Naomi Kelman received an equity award of 7,392 restricted stock units (RSUs), each convertible into one share of common stock. The RSUs were granted at $0 cost and will vest in full on the first anniversary of the grant date, subject to continued service. Following the award, Kelman’s total direct beneficial ownership increased to 41,041 shares.
No shares were sold and no cash was exchanged, indicating the transaction is a routine annual equity grant designed to align director incentives with shareholder interests. No derivative positions or additional transactions were reported.
National Vision Holdings, Inc. (EYE) – Form 4 insider filing
Director Susan S. Johnson reported the award of 7,392 restricted stock units (RSUs) on 18 June 2025. Each RSU represents the right to receive one share of common stock upon vesting. According to the filing, these RSUs vest in full on the first anniversary of the grant date, aligning the director’s compensation with long-term shareholder value. No cash was paid for the units (reported price $0), indicating a standard equity incentive grant rather than an open-market purchase. Following the award, Johnson’s total beneficial ownership stands at 43,700 shares, all held directly.
The filing was signed on 23 June 2025 by attorney-in-fact Jared Brandman and contains no indication of share sales, option exercises or transfers. There are also no derivative transactions disclosed in Table II, suggesting the director’s exposure is limited to common stock and outstanding equity awards.
While Form 4s do not provide company-wide financial data, incremental insider accumulation can serve as a sentiment indicator. However, given the modest size relative to National Vision’s ~83 million share float (per last 10-K), the transaction is unlikely to be financially material to the enterprise. Investors may view the grant as routine board compensation rather than a signal of imminent corporate developments.
National Vision Holdings, Inc. (EYE) Form 4 snapshot: Director Virginia A. Hepner was granted 7,392 restricted stock units (RSUs) on 18 Jun 2025 at no cost (transaction code "A"). Following the grant, her beneficial ownership rose to 44,027 common shares.
The RSUs convert into an equal number of common shares and vest in full one year after the grant date, providing equity-based alignment between the director and shareholders. No sales, purchases for cash, or derivative transactions were reported. The filing was electronically signed on 23 Jun 2025.
On June 17, 2025, Stardust Power Inc. (SDST) signed an Underwriting Agreement with Aegis Capital Corp. for a firm-commitment public offering of 21,500,000 common shares at $0.20 per share. Gross proceeds total approximately $4.3 million before underwriting discounts and offering expenses, with an additional 45-day over-allotment option for up to 3,225,000 shares.
The shares were issued under the Company’s Form S-1 (File No. 333-287939) declared effective on June 16, 2025; closing for the Firm Shares occurred on June 18, 2025. Net proceeds are earmarked to complete the Definitive Feasibility Study (DFS/FEL-3) for the proposed lithium processing facility in Muskogee, Oklahoma, supporting the Company’s strategy to become a domestic lithium supplier.
The Underwriting Agreement includes standard representations, warranties, indemnification, and termination provisions and is filed as Exhibit 1.1. Press releases covering pricing (June 17) and closing (June 18) are attached as Exhibits 99.1 and 99.2, respectively.
This capital raise supplies near-term liquidity for project development but also introduces material shareholder dilution at a relatively low offering price, indicating a higher cost of capital for the Company and underscoring the importance of executing the DFS on schedule.